Suministro Inhaladores y Otros
PROVEER MEDICAMENTOS A PACIENTES BENEFICIARIOS DEL HBSJO
11 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1063535-6732-SE26 | 02-07-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.229.984 |
| 1063535-6653-SE26 | 22-06-2026 | Laboratorios Kampar S.A. | $578.340 |
| 1063535-6639-SE26 | 19-06-2026 | Laboratorios Kampar S.A. | $514.080 |
| 1063535-6611-SE26 | 16-06-2026 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-6562-SE26 | 12-06-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $3.382.456 |
| 1063535-6498-SE26 | 08-06-2026 | Guillermo Harding y Compania Limitada | $253.416 |
| 1063535-6470-SE26 | 01-06-2026 | Laboratorios Saval S.A. | $130.662 |
| 1063535-6452-SE26 | 29-05-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.229.984 |
| 1063535-6379-SE26 | 22-05-2026 | Laboratorios Kampar S.A. | $514.080 |
| 1063535-6360-SE26 | 19-05-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.229.984 |
| 1063535-6359-SE26 | 18-05-2026 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-6315-SE26 | 13-05-2026 | Guillermo Harding y Compania Limitada | $253.416 |
| 1063535-6221-SE26 | 04-05-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $2.459.968 |
| 1063535-6228-SE26 | 04-05-2026 | Guillermo Harding y Compania Limitada | $168.944 |
| 1063535-6106-SE26 | 22-04-2026 | Laboratorios Kampar S.A. | $514.080 |
| 1063535-6063-SE26 | 17-04-2026 | Laboratorios Saval S.A. | $130.662 |
| 1063535-6036-SE26 | 14-04-2026 | Etex Farmaceutica Limitada | $599.760 |
| 1063535-6017-SE26 | 13-04-2026 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-5976-SE26 | 07-04-2026 | Guillermo Harding y Compania Limitada | $168.944 |
| 1063535-5871-SE26 | 27-03-2026 | Guillermo Harding y Compania Limitada | $168.944 |
| 1063535-5804-SE26 | 24-03-2026 | Laboratorios Kampar S.A. | $428.400 |
| 1063535-5710-SE26 | 12-03-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $1.229.984 |
| 1063535-5697-SE26 | 11-03-2026 | Laboratorios Saval S.A. | $119.774 |
| 1063535-5660-SE26 | 06-03-2026 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-5587-SE26 | 26-02-2026 | Laboratorios Kampar S.A. | $514.080 |
| 1063535-5581-SE26 | 26-02-2026 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-5564-SE26 | 25-02-2026 | Guillermo Harding y Compania Limitada | $337.889 |
| 1063535-5568-SE26 | 25-02-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $614.992 |
| 1063535-5405-SE26 | 06-02-2026 | Laboratorios Saval S.A. | $119.774 |
| 1063535-5270-SE26 | 23-01-2026 | Laboratorios Kampar S.A. | $462.672 |
| 1063535-5097-SE26 | 09-01-2026 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-5039-SE26 | 05-01-2026 | Laboratorios Kampar S.A. | $462.672 |
| 1063535-5016-SE26 | 02-01-2026 | Guillermo Harding y Compania Limitada | $337.889 |
| 1063535-5023-SE26 | 02-01-2026 | Guillermo Harding y Compania Limitada | $935.935 |
| 1063535-16976-SE25 | 23-12-2025 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-16737-SE25 | 27-11-2025 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-16740-SE25 | 27-11-2025 | Laboratorios Kampar S.A. | $462.672 |
| 1063535-16675-SE25 | 21-11-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.844.976 |
| 1063535-16642-SE25 | 14-11-2025 | Laboratorios Kampar S.A. | $462.672 |
| 1063535-16615-SE25 | 10-11-2025 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-16515-SE25 | 24-10-2025 | Etex Farmaceutica Limitada | $160.650 |
| 1063535-16503-SE25 | 21-10-2025 | Farmaceutica Insuval S.A. | $71.400 |
| 1063535-16379-SE25 | 07-10-2025 | Laboratorios Kampar S.A. | $462.672 |
| 1063535-10368-SE25 | 24-09-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $696.269 |
| 1063535-10306-SE25 | 15-09-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $1.044.404 |
| 1063535-10292-SE25 | 11-09-2025 | Etex Farmaceutica Limitada | $160.650 |
| 1063535-10288-SE25 | 11-09-2025 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-10227-SE25 | 04-09-2025 | Guillermo Harding y Compania Limitada | $337.889 |
| 1063535-10121-SE25 | 21-08-2025 | Laboratorios Saval S.A. | $130.662 |
| 1063535-10113-SE25 | 20-08-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.785.076 |
| 1063535-10098-SE25 | 19-08-2025 | Laboratorios Kampar S.A. | $963.900 |
| 1063535-10045-SE25 | 14-08-2025 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-9996-SE25 | 07-08-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $922.488 |
| 1063535-9889-SE25 | 28-07-2025 | Guillermo Harding y Compania Limitada | $467.968 |
| 1063535-9851-SE25 | 23-07-2025 | Laboratorios Kampar S.A. | $963.900 |
| 1063535-9776-SE25 | 17-07-2025 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-9759-SE25 | 14-07-2025 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-9593-SE25 | 23-06-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $614.992 |
| 1063535-9488-SE25 | 06-06-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $614.992 |
| 1063535-9492-SE25 | 06-06-2025 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-9437-SE25 | 02-06-2025 | Laboratorios Kampar S.A. | $963.900 |
| 1063535-9364-SE25 | 26-05-2025 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-9218-SE25 | 08-05-2025 | Laboratorios Kampar S.A. | $861.084 |
| 1063535-9174-SE25 | 02-05-2025 | Etex Farmaceutica Limitada | $214.200 |
| 1063535-9125-SE25 | 25-04-2025 | Laboratorios Kampar S.A. | $861.084 |
| 1063535-9016-SE25 | 16-04-2025 | Farmaceutica Insuval S.A. | $476.000 |
| 1063535-8917-SE25 | 04-04-2025 | Laboratorios Kampar S.A. | $861.084 |
| 1063535-3758-SE25 | 17-03-2025 | Etex Farmaceutica Limitada | $299.880 |
| 1063535-3734-SE25 | 13-03-2025 | Guillermo Harding y Compania Limitada | $467.968 |
| 1063535-3701-SE25 | 07-03-2025 | Laboratorios Saval S.A. | $217.770 |
| 1063535-529-SE25 | 27-02-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $273.105 |
| 1063535-400-SE25 | 12-02-2025 | Laboratorios Kampar S.A. | $861.084 |
| 1063535-313-SE25 | 04-02-2025 | Guillermo Harding y Compania Limitada | $337.889 |
| 1063535-186-SE25 | 21-01-2025 | Laboratorios Kampar S.A. | $899.640 |
| 1063535-139-SE25 | 15-01-2025 | Etex Farmaceutica Limitada | $299.880 |
| 1063535-65-SE25 | 08-01-2025 | Pfizer Chile S.A. | $881.780 |
| 1063535-40-SE25 | 06-01-2025 | Laboratorios Kampar S.A. | $861.084 |
| 1063535-2940-SE24 | 18-12-2024 | Etex Farmaceutica Limitada | $299.880 |
| 1063535-2924-SE24 | 18-12-2024 | Laboratorios Kampar S.A. | $861.084 |
| 1063535-2818-SE24 | 09-12-2024 | Pfizer Chile S.A. | $881.780 |
| 1063535-2807-SE24 | 06-12-2024 | Laboratorios Kampar S.A. | $428.400 |
| 1063535-2726-SE24 | 27-11-2024 | Farmaceutica Insuval S.A. | $71.400 |
| 1063535-2641-SE24 | 13-11-2024 | Laboratorios Kampar S.A. | $428.400 |
| 1063535-2633-SE24 | 12-11-2024 | Etex Farmaceutica Limitada | $160.650 |
| 1063535-2592-SE24 | 08-11-2024 | Pfizer Chile S.A. | $881.780 |
| 1063535-2584-SE24 | 07-11-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $218.484 |
| 1063535-2435-SE24 | 17-10-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $327.726 |
| 1063535-2423-SE24 | 17-10-2024 | Etex Farmaceutica Limitada | $160.650 |
| 1063535-2418-SE24 | 16-10-2024 | Pfizer Chile S.A. | $881.780 |
| 1063535-2242-SE24 | 25-09-2024 | Etex Farmaceutica Limitada | $160.650 |
| 1063535-2016-SE24 | 29-08-2024 | Etex Farmaceutica Limitada | $160.650 |
| 1063535-2015-SE24 | 29-08-2024 | Etex Farmaceutica Limitada | $691.390 |
Fuente original:ficha mercadopublico.cl
